InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 264102

Monday, 10/24/2016 8:40:07 PM

Monday, October 24, 2016 8:40:07 PM

Post# of 345764
Now since Garnick was back on the cc and we see the connections from this past post, I wonder what Peter Thiel has up his sleeve for Peregrine Pharmaceuticals

https://www.technologyreview.com/s/541226/peter-thiel-explains-biotech-investing-rationale-get-rid-of-randomness/

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News